文献速递认知障碍与痴呆癫痫

阿尔茨海默病与癫痫:一项孟德尔随机化研究

Alzheimer Disease and Epilepsy: A Mendelian Randomization Study.
PubMed 文献 · Neurology · 2023-05-24

该研究采用两样本双向孟德尔随机化方法,利用欧洲人群大规模全基因组关联研究的遗传工具变量,探索阿尔茨海默病遗传易感性、脑脊液生物标志物与各类型癫痫之间的因果关系。结果支持阿尔茨海默病、淀粉样蛋白病理与全面性癫痫之间存在因果关联,并提示阿尔茨海默病与局灶性海马硬化密切相关;反向分析提示局灶性海马硬化对阿尔茨海默病有提示性效应。

要点

  • 阿尔茨海默病遗传易感性增加全面性癫痫风险(OR 1.053,95%CI 1.002-1.105,p=0.038)。
  • 阿尔茨海默病遗传易感性增加局灶性海马硬化风险(OR 1.013,95%CI 1.004-1.022,p=0.004)。
  • 反向分析提示局灶性海马硬化对阿尔茨海默病有提示性效应(OR 3.994,95%CI 1.172-13.613,p=0.027)。

核心结论

  • 该孟德尔随机化研究支持阿尔茨海默病、淀粉样蛋白病理与全面性癫痫之间存在因果关联。
  • 研究还提示阿尔茨海默病与局灶性海马硬化之间存在密切关联。
  • 作者认为应更多努力筛查阿尔茨海默病患者的癫痫发作、阐明其临床意义并探索其作为假定可调控风险因素的作用。

研究设计与样本

  • 采用两样本双向孟德尔随机化方法。
  • 遗传工具变量取自欧洲血统人群的大规模全基因组荟萃分析:阿尔茨海默病(病例/代理 N=111,326,对照 N=677,663)、阿尔茨海默病脑脊液生物标志物(Aβ42 和 pTau,N=13,116)以及癫痫(病例 N=15,212,对照 N=29,677)。
  • 癫痫表型包括全部癫痫、全面性癫痫、局灶性癫痫、儿童失神癫痫、青少年失神癫痫、青少年肌阵挛癫痫、伴强直-阵挛发作的全面性癫痫、伴海马硬化的局灶性癫痫(focal HS)以及病灶阴性局灶性癫痫。
  • 主要分析采用广义汇总数据孟德尔随机化方法;敏感性分析包括逆方差加权、MR-PRESSO、MR-Egger、加权众数和加权中位数。

主要发现

  • 正向分析中,阿尔茨海默病遗传易感性与全面性癫痫风险增加相关(OR 1.053,95%CI 1.002-1.105,p=0.038)。
  • 正向分析中,阿尔茨海默病遗传易感性与局灶性海马硬化风险增加相关(OR 1.013,95%CI 1.004-1.022,p=0.004);这些关联在敏感性分析中一致,并使用另一阿尔茨海默病全基因组关联研究的独立遗传工具变量集重复验证。
  • 反向分析中,局灶性海马硬化对阿尔茨海默病有提示性效应(OR 3.994,95%CI 1.172-13.613,p=0.027)。
  • 遗传预测的较低脑脊液Aβ42水平与全面性癫痫风险增加相关(β=0.090,95%CI 0.022-0.158,p=0.010)。

临床怎么用

  • 作者认为应更多努力筛查阿尔茨海默病患者的癫痫发作、阐明其临床意义并探索其作为假定可调控风险因素的作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Observational studies suggested a bidirectional relationship between Alzheimer disease (AD) and epilepsies. However, it remains debated whether and in which direction a causal association exists. This study aims to explore the relationship between genetic predisposition to AD, CSF biomarkers of AD (β-amyloid [Aβ] 42 and phosphorylated tau [pTau]), and epilepsies with 2-sample, bidirectional Mendelian randomization (MR) method. METHODS: Genetic instruments were obtained from large-scale genome-wide meta-analysis of AD (Ncase/proxy = 111,326, Ncontrol = 677,663), CSF biomarkers of AD (Aβ42 and pTau, N = 13,116), and epilepsy (Ncase = 15,212, Ncontrol = 29,677) of European ancestry. Epilepsy phenotypes included all epilepsy, generalized epilepsy, focal epilepsy, childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, generalized epilepsy with tonic-clonic seizures, focal epilepsy with hippocampal sclerosis (focal HS), and lesion-negative focal epilepsy. Main analyses were performed using generalized summary data-based MR. Sensitivity analyses included inverse variance weighted, MR pleiotropy residual sum and outlier, MR-Egger, weighted mode, and weighted median. RESULTS: For forward analysis, genetic predisposition to AD was associated with an increased risk of generalized epilepsy (odds ratio [OR] 1.053, 95% CI 1.002-1.105, p = 0.038) and focal HS (OR 1.013, 95% CI 1.004-1.022, p = 0.004). These associations were consistent across sensitivity analyses and replicated using a separate set of genetic instruments from another AD genome-wide association study. For reverse analysis, there was a suggestive effect of focal HS on AD (OR 3.994, 95% CI 1.172-13.613, p = 0.027). In addition, genetically predicted lower CSF Aβ42 was associated with an increased risk of generalized epilepsy (β = 0.090, 95% CI 0.022-0.158, p = 0.010). DISCUSSION: This MR study supports a causal link between AD, amyloid pathology, and generalized epilepsy. This study also indicates a close association between AD and focal HS. More effort should be made to screen seizure in AD, unravel its clinical implications, and explore its role as a putative modifiable risk factor.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Fang Y, Si X, Wang J, et al. Alzheimer Disease and Epilepsy: A Mendelian Randomization Study. Neurology. 2023. PMID: 37225432. doi:10.1212/WNL.0000000000207423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。